From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA-approved, bioengineered living-cell therapy can shift genomic profile of non-healing wounds

from News-Medical.net

Apligraf — an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. — has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a treated non-healing wound, according to new research published in the peer-reviewed journal Science Translational Medicine. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063